This inventor holds 1 USPTO granted patent. Top assignee: Aventis Research & Technologies Gmbh & Co Kg. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Ann-Charlotte Thuresson: Innovator in Nucleic Acid Research
Introduction
Ann-Charlotte Thuresson is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of nucleic acid research, particularly through his innovative work on poly(A)-specific 3′-exonuclease activity. His research has implications for pharmaceutical and diagnostic applications.
Latest Patents
Thuresson holds a patent for a method related to 3′-exonuclease, titled "3′-exonuclease, production and use thereof." This invention pertains to a poly(A)-specific 3′-exonuclease activity that can be obtained by chromatographically purifying a crude extract of animal or human cells. The patent outlines its use for deadenylating 3′-poly(A) tails of nucleic acids and as a pharmaceutical or diagnostic agent, or for identifying functional interactors. He has 1 patent to his name.
Career Highlights
Ann-Charlotte Thuresson is associated with Aventis Research & Technologies GmbH & Co. KG, where he continues to advance his research in the field. His work has been instrumental in developing new methodologies that enhance our understanding of nucleic acids.
Collaborations
He has collaborated with notable colleagues, including Christoph Hül and Karl-Christian Gallert, contributing to a dynamic research environment that fosters innovation.
Conclusion
Ann-Charlotte Thuresson is a distinguished inventor whose work in nucleic acid research has paved the way for new diagnostic and therapeutic approaches. His contributions continue to impact the scientific community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile